CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-248967 |
|---|---|
| Form Type | 4 |
| Filing Date | May 29, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
225,000
Total Value
$5,539,193.74
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | May 27, 2026 | Exercise/Conversion | 75,000 | $8.27 | $620,250.00 | 83,977 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | May 27, 2026 | Sale | 54,575 | $65.37 | $3,567,627.78 | 29,402 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | May 27, 2026 | Sale | 20,425 | $66.16 | $1,351,315.96 | 8,977 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | May 27, 2026 | Exercise/Conversion | 75,000 | $0.00 | $0.00 | 166,986 | Direct | โ | View Details |